Form 4: HealthEquity EVP Delano Ladd Sells Stock

Delano Ladd, EVP and General Counsel of HealthEquity, Inc., executed a pre-planned sale of 1,500 shares of common stock at $92.07 per share.

Summary

• Delano Ladd, Executive Vice President and General Counsel of HealthEquity, Inc. (HQY), reported a transaction involving the company's common stock.
• On October 20, 2025, Mr. Ladd disposed of 1,500 shares of HealthEquity common stock.
• The shares were sold at a price of $92.07 per share.
• Following this transaction, Mr. Ladd beneficially owns 76,979 shares of HealthEquity common stock.
• The transaction was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Ladd on June 12, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale can be perceived negatively, the fact that it was executed under a Rule 10b5-1 plan mitigates concerns, indicating a pre-planned, routine liquidity event rather than a reaction to adverse company news.

Positives

• The sale was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a scheduled liquidity event rather than a reaction to new material non-public information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived by the market as a lack of confidence or a move to diversify holdings, potentially leading to minor negative sentiment.

Risks

• Potential for negative market perception if investors misinterpret the routine nature of a 10b5-1 plan sale as a signal of underlying company issues.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, common across all publicly traded companies. It reflects an individual executive's pre-planned stock sale rather than a broader industry trend or company-specific strategic move.

Stakeholder Impact

• Shareholders: May observe the insider sale, but the 10b5-1 plan context suggests it's a routine personal financial management decision rather than a signal of company distress.

Key Dates

Keywords

HealthEquity, HQY, Delano Ladd, Insider Sale, Form 4, 10b5-1 Plan, Executive Transaction, Common Stock